Spyre Therapeutics, Inc. · NASDAQ:SYRE
Rtw Investments, LP's stake in Spyre Therapeutics, Inc. fell to 4.80% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Rtw Investments, LP's stake in Spyre Therapeutics, Inc. fell to 4.80%, 4,251,996 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 4.80%
- Shares
- 4,251,996
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| RTW Investments, LP | 4.80% | 4,251,996 |
| Roderick Wong | 4.80% | 4,251,996 |
Source
Related
- Spyre Therapeutics, Inc.
- Rtw Investments, LP
- Spyre Therapeutics, Inc. shareholders
- Schedule 13G/A · Rtw Investments, LP · Feb 14, 2025
- Schedule 13D/A · Harwin Peter Evan · Oct 9, 2026
- Form 4 · Burrows Scott L · Oct 2, 2026
- Form 4 · King-Jones Heidy · Oct 2, 2026
- Form 4 · Turtle Cameron · Oct 2, 2026
- Schedule 13G · Paradigm Biocapital Advisors LP · Oct 1, 2026